Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by 1hot-techwomanon Jun 27, 2019 7:01am
62 Views
Post# 29868565

RE:RE:Aleafia and Vivo very similiar companys...look at Q1 numbers

RE:RE:Aleafia and Vivo very similiar companys...look at Q1 numbers
srtman03 wrote:
srtman03 wrote: Aleafia Health revenue was $1.5 million, compared to $0.1 million in Q1 2018, a 1,723 per cent year-over-year increase. The Company experience a net loss of $20.2 million, or a $7 million net loss, excluding $13.2 million in one-time, non-cash payments resulting from the closing of the Emblem acquisition. The Company has $36.8 million cash on hand at March 31, 2019, compared to $26.4 million at December 31, 2018. Current assets, including cash, totalled $61 million at March 31, 2019, compared to $29.2 million at December 31, 2018....................................................................................................................................................................................................................................................................................................................... VIVO Cannabis Reports Q1 2019 Financial Results -- Net revenue of $5.1 million, compared to $5.8 million in Q4 2018 -- Q4 2018 sales benefited from initial product stocking by provincial distributors -- Adjusted EBITDA of ($2.2M), compared to ($7.3M) in Q4 2018 -- Cash and short-term investments (excluding strategic equity investments) of $68.4 million as at March 31, 2019


Little skewed is it not especially when Vivo is a larger LP ......Amazing to say the least...LOL All being done for a takeover !!


I think you are bang on there !!! Aleafia has same share count as Vivo and is smaller than Vivo in business as well. There last Q1 numbers were terrible and there at $1.23 and Vivo at $0.44? makes no sense ......
<< Previous
Bullboard Posts
Next >>